EE491 Cost-Effectiveness of paclitaxel Monotherapy Versus paclitaxel Plus Bevacizumab Combination Therapy in Triple-Negative Breast Cancer

Abstract

Authors

S Yande AA Deshmukh

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×